Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Combining lisinopril and L-arginine slows disease progression and reduces endothelin-1 in passive Heymann nephritis — Carla Zoja (2003) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Combining lisinopril and L-arginine slows disease progression and reduces endothelin-1 in passive Heymann nephritis
Shared by
Giuseppe Remuzzi
Combining lisinopril and L-arginine slows disease progression and reduces endothelin-1 in passive Heymann nephritis
Article
2003
en
Authors
+4 more
CZ
Carla Zoja
AB
Ariela Benigni
DC
Davide Camozzi
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1987
Indomethacin reduces proteinuria in passive Heymann nephritis in rats
Carla Zoja
,
Ariela Benigni
,
P Verroust
,
Pierre Ronco
,
Tullio Bertani
,
Giuseppe Remuzzi
Article
1997
Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
Carla Zoja
,
Daniela Corna
,
Isabella Bruzzi
,
Chiara Foglieni
,
Tullio Bertani
,
Giuseppe Remuzzi
,
Ariela Benigni
Article
1999
Angiotensin-converting enzyme inhibition prevents loss of glomerular hydraulic permeability in passive heymann nephritis.
Andrea Remuzzi
,
Nives Monaci
,
Maria Enrica Bonassi
,
Daniela Corna
,
Carla Zoja
,
Ehab I. Mohammed
,
Giuseppe Remuzzi
Article
1994
Endothelin and renal disease progression.
Giuseppe Remuzzi
,
Ariela Benigni
Article
2015
Vascular Endothelin and Renal Disease Progression
Norberto Perico
,
Giuseppe Remuzzi
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.